全文获取类型
收费全文 | 55371篇 |
免费 | 5493篇 |
国内免费 | 3377篇 |
专业分类
耳鼻咽喉 | 539篇 |
儿科学 | 1189篇 |
妇产科学 | 253篇 |
基础医学 | 3384篇 |
口腔科学 | 1082篇 |
临床医学 | 6678篇 |
内科学 | 4717篇 |
皮肤病学 | 494篇 |
神经病学 | 1092篇 |
特种医学 | 1850篇 |
外国民族医学 | 3篇 |
外科学 | 5335篇 |
综合类 | 15875篇 |
现状与发展 | 10篇 |
预防医学 | 6394篇 |
眼科学 | 641篇 |
药学 | 6653篇 |
82篇 | |
中国医学 | 5851篇 |
肿瘤学 | 2119篇 |
出版年
2024年 | 477篇 |
2023年 | 780篇 |
2022年 | 1817篇 |
2021年 | 2301篇 |
2020年 | 1974篇 |
2019年 | 1060篇 |
2018年 | 1174篇 |
2017年 | 1616篇 |
2016年 | 1210篇 |
2015年 | 2132篇 |
2014年 | 2789篇 |
2013年 | 3367篇 |
2012年 | 4855篇 |
2011年 | 5247篇 |
2010年 | 4982篇 |
2009年 | 4623篇 |
2008年 | 4614篇 |
2007年 | 4185篇 |
2006年 | 3834篇 |
2005年 | 3063篇 |
2004年 | 2123篇 |
2003年 | 1685篇 |
2002年 | 1279篇 |
2001年 | 1198篇 |
2000年 | 881篇 |
1999年 | 375篇 |
1998年 | 83篇 |
1997年 | 83篇 |
1996年 | 90篇 |
1995年 | 44篇 |
1994年 | 62篇 |
1993年 | 28篇 |
1992年 | 30篇 |
1991年 | 14篇 |
1990年 | 14篇 |
1989年 | 19篇 |
1988年 | 6篇 |
1987年 | 13篇 |
1986年 | 23篇 |
1985年 | 12篇 |
1984年 | 5篇 |
1983年 | 7篇 |
1982年 | 3篇 |
1963年 | 2篇 |
1962年 | 4篇 |
1959年 | 4篇 |
1958年 | 6篇 |
1957年 | 13篇 |
1956年 | 9篇 |
1955年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
子宫内膜癌PTEN蛋白表达及其临床意义 总被引:2,自引:0,他引:2
目的 :探讨抑癌基因第 10染色体同源丢失性磷酸酶 -张力蛋白基因 (PTEN)蛋白表达与子宫内膜癌的发生、发展及复发的关系。方法 :采用免疫组织化学S P法检测PTEN蛋白在 5 0例子宫内膜癌、12例不典型增生子宫内膜及 10例正常子宫内膜组织的表达。结果 :5 0例子宫内膜癌中PTEN蛋白表达率为 5 6 0 0 % ,明显低于正常子宫内膜以及不典型增生子宫内膜中的表达 (10 0 0 0 %、91 0 0 % ) (P <0 0 5 )。PTEN蛋白在无肌层浸润或肌层浸润≤ 1/ 2的子宫内膜癌中阳性表达率为 76 0 0 % ,肌层浸润 >1/ 2或有淋巴结转移者为 36 0 0 % ,与肌层浸润程度显著相关 (P <0 0 5 ) ,且Ia Ib期与Ic期相比也有统计学差异 ;但与子宫内膜癌的组织学分级、有无复发无关 (P >0 0 5 )。结论 :抑癌基因PTEN蛋白表达缺失在子宫内膜癌的发生、发展、浸润及复发过程中有一定作用。 相似文献
82.
83.
目的 :观察硝酸甘油在麻醉手术中控制血压的效果。方法 :46例病人均采用静脉复合麻醉 ,对在麻醉前和麻醉手术过程中血压过高者静脉滴注硝酸甘油观察血压下降的情况 ,并对用药量和用药前后血压、HR进行记录。结果 :用药3分钟血压开始下降 ,5分钟达到理想的范围 ,平均用量 (4±1 1)mg,部分病人心率加快 ,1例出现心动过速 ,静脉注射艾司洛尔20mg后降至正常范围。结论 :硝酸甘油降压可控性强 ,副作用少。 相似文献
84.
85.
目的:探讨左乙拉西坦与苯巴比妥的药物相互作用及作用机制。方法:临床药师通过神经内科ICU的一例伴难以控制、反复发作癫的急性重症脑炎病例用药发现问题,查阅病历资料及相关文献进行分析。结果:左乙拉西坦可引起苯巴比妥血药浓度降低,可能与两者竞争结合P糖蛋白有关。结论:临床药师应该加强对左乙拉西坦的药物相互作用的观察和研究,以促进抗癫药物的合理应用。 相似文献
86.
目的 建立TLC及HPLC法定性定量测定尖瓣过路黄中槲皮素和山柰酚.方法 TLC法确定黄酮类化合物的种类,HPLC法测定山柰酚、槲皮素的含量.结果 槲皮素在0.081 6-0.571 2μg范围内线性关系良好(R2=0.999 4);平均回收率101.88%,RSD=1.572 4%,n=6.山柰酚在0.069 6-0... 相似文献
87.
Fatigue Cracking Evolution and Model of Cold Recycled Asphalt Mixtures during Different Curing Times
This paper aims to investigate the fatigue cracking evolution of cold recycled asphalt mixtures with asphalt emulsion (CRME) under different curing times. The fatigue cracking model of CRME based on damage mechanics and fracture mechanics was analyzed according to the fatigue loading curve. Firstly, the fatigue cracking evolution of CRME was studied through an SCB strength test and SCB fatigue test. Then, the fatigue damage mechanics were used to establish a nonlinear fatigue cracking model, and the damage degree of CRME at the initial cracking point was determined. The Paris formula was used to characterize the law of fatigue crack propagation. Finally, the microstructure of CRME was observed by scanning electron microscopy (SEM) with the backscattering method. The results indicate that the initial cracking point appears at around 60% of the fatigue life according to the SCB fatigue test by means of image analysis. The damage variable was obtained through the cracking model, and the value of the damage variable was determined as 0.06–0.17 at the initial cracking point. In addition, the Paris formula showed that the crack growth of CRME can be reflected by the stress intensity factor and correlative parameters. Moreover, cement hydration products were mixed with the asphalt membrane to form a denser spatial structure during the curing process, which may provide higher fatigue performance of CRME. This research may provide a theoretical reference for studying the fatigue cracking behavior of CRME. 相似文献
88.
临床上骨科内固定手术后,由于感染或者感染后形成的高抗药性生物膜,在全身应用大剂量抗生素的情况下,病灶局部组织仍难达到有效的抗生素浓度,使感染久治难愈,导致内固定失败,为了减少术后感染的发生,可以使用载抗生素内植入物来进行治疗,或者在感染后经过清创后再次使用载抗生素内植入物进行治疗.本文对载抗生素内植入物的研究进展作一综述. 相似文献
89.
90.
Yang Bai Liang Wen Yulong Zhao Jianan Li Chen Guo Xiaobin Zhang Jiaming Yang Yushu Dong Litian Ma Guobiao Liang Yun Kou Enxin Wang 《Medicine》2022,101(18)
Information about coronavirus disease 2019 (COVID-19) patients with pre-existing chronic obstructive pulmonary disease (COPD) is still lacking. The aim of this study is to describe the clinical course and the outcome of COVID-19 patients with comorbid COPD.This retrospective study was performed at Wuhan Huoshenshan Hospital in China. Patients with a clear diagnosis of COVID-19 who had comorbid COPD (N = 78) were identified. COVID-19 patients without COPD were randomly selected and matched by age and sex to those with COPD. Clinical data were analyzed and compared between the two groups. The composite outcome was the onset of intensive care unit admission, use of mechanical ventilation, or death during hospitalization. Multivariable Cox regression analyses controlling for comorbidities were performed to explore the relationship between comorbid COPD and clinical outcome of COVID-19.Compared to age- and sex-matched COVID-19 patients without pre-existing COPD, patients with pre-existing COPD were more likely to present with dyspnea, necessitate expectorants, sedatives, and mechanical ventilation, suggesting the existence of acute exacerbations of COPD (AECOPD). Greater proportions of patients with COPD developed respiratory failure and yielded poor clinical outcomes. However, laboratory tests did not show severer infection, over-activated inflammatory responses, and multi-organ injury in patients with COPD. Kaplan–Meier analyses showed patients with COPD exhibited longer viral clearance time in the respiratory tract. Multifactor regression analysis showed COPD was independently correlated with poor clinical outcomes.COVID-19 patients with pre-existing COPD are more vulnerable to AECOPD and subsequent respiratory failure, which is the main culprit for unfavorable clinical outcomes. However, COPD pathophysiology itself is not associated with over-activated inflammation status seen in severe COVID-19. 相似文献